Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Nov;83(5):607-635.
doi: 10.1016/j.jinf.2021.08.013. Epub 2021 Aug 11.

Changes in the pathogenic spectrum of acute respiratory tract infections during the COVID-19 epidemic in Beijing, China: A large-scale active surveillance study

Mei Dong  1 , Ming Luo  1 , Aihua Li  1 , Hui Xie  1 , Cheng Gong  1 , Juan Du  2 , Xinrui Wang  2 , Maozhong Li  1 , Xue Wang  1 , Yiting Wang  1 , Haiyan Zhang  3 , Xiaoxing Yang  4 , Wei Cai  5 , Hongjun Li  6 , Wenzeng Zhang  7 , Lijun Ren  8 , Qing-Bin Lu  9 , Fang Huang  10
Affiliations
Comment

Changes in the pathogenic spectrum of acute respiratory tract infections during the COVID-19 epidemic in Beijing, China: A large-scale active surveillance study

Mei Dong et al. J Infect. 2021 Nov.
No abstract available

PubMed Disclaimer

Figures

Fig 1
Fig. 1
Spatial and temporal distribution of the samples and pathogenic spectrum from acute respiratory tract infections before the COVID-19 and during the COVID-19. A, the distribution of 35 sentinel hospitals. The red dot represents the location of the hospital. B, the monthly distribution of samples. The red line represents the number of samples from ARTI during the epidemic of the COVID-19. The black line represents the mean number of samples from ARTI before the epidemic of the COVID-19. The long dash gray line represents the max number of samples from ARTI before the epidemic of the COVID-19. The dot dash gray line represents the min number of samples from ARTI before the epidemic of the COVID-19. The blue column represents the number of the COVID-19 patients using the right vertical axis. C, the pie chart for pathogenic spectrum of acute respiratory tract infections before the COVID-19; D, the pie chart for pathogenic spectrum of acute respiratory tract infections during the COVID-19; E, the column chart for pathogenic spectrum of acute respiratory tract infections for the children; F, the column chart for pathogenic spectrum of acute respiratory tract infections for the adults. E-F, the gray column represents the proportion of the pathogen before the COVID-19; the blue column represents the proportion of the pathogen during the COVID-19, which decreased compared to that before the COVID-19; the red column represents the proportion of the pathogen during the COVID-19, which increased compared to that before the COVID-19. The period between 1 February 2015 and 31 January 2020 for the control was as before the COVID-19 and the period between 1 February 2020 and 31 January 2021 was as during the COVID-19. COVID-19, coronavirus disease 2019.
Fig 2
Fig. 2
The positive rate and dynamic profiles of the pathogens from acute respiratory tract infection before and during the COVID-19. A, the positive rate of the pathogens as a whole and in the children and in the adults; the star means the significant difference between the positive rates before and during the COVID-19 by chi square test; The gray column represents the proportion of the pathogen before the COVID-19; the blue column represents the proportion of the pathogen during the COVID-19, which decreased compared to that before the COVID-19; the red column represents the proportion of the pathogen during the COVID-19, which increased compared to that before the COVID-19; B, the difference (upper half part) and difference proportion (lower half part) between the positive rates before and during the COVID-19 as a whole; C, the difference (upper half part) and difference proportion (lower half part) between the positive rates before and during the COVID-19 in the children; D, the difference (upper half part) and difference proportion (lower half part) between the positive rates before and during the COVID-19 in the adults; B-D, the green column/dot represents the decrease difference/difference proportion; the purple column/dot represents the increase difference/difference proportion; The difference of positive rates was defined as the positive rate during the COVID-19 minus the positive rate before the COVID-19. The difference proportion (%) was defined as the difference of positive rate (%) divided by the detection rate before the COVID-19. E, overall; F, seasonal HCoV; G, HPIV; H, HRV; I, EV; J, HBoV; K, IFV; L, MP; M, HMPV; N, HAdV; O, CP; P, RSV. The red line represents the positive rate during the epidemic of the COVID-19. The blue line represents the positive rate before the epidemic of the COVID-19. The long dash gray line represents the max positive rate before the epidemic of the COVID-19. The dot dash gray line represents the min positive rate before the epidemic of the COVID-19. The right multi-colored strip represents the time line of the PHER in Beijing during from 1 February 2020 to 31 January 2021. The red part represents the PHER Level I; the yellow part represents the PHER Level II; the light blue part represents the PHER Level III. PHER, public health emerging response. The dark blue column represents the number of the COVID-19 patients in Beijing.
See this image and copyright information in PMC

Comment on

References

    1. Poole S., Brendish N.J., Clark T.W. SARS-CoV-2 has displaced other seasonal respiratory viruses: results from a prospective cohort study. J Infect. Dec 2020;81(6):966–972. PubMed PMID: 33207254. Pubmed Central PMCID: PMC7666810. Epub 2020/11/19. - PMC - PubMed
    1. Zhang N., Jia W., Lei H., Wang P., Zhao P., Guo Y., et al. Effects of human behaviour changes during the COVID-19 pandemic on influenza spread in Hong Kong. Clin Infect Dis. 2020 Dec 4 PubMed PMID: 33277643. Pubmed Central PMCID: PMC7799278. Epub 2020/12/06. - PMC - PubMed
    1. Soo R.J.J., Chiew C.J., Ma S., Pung R., Lee V. Decreased Influenza Incidence under COVID-19 Control Measures, Singapore. Emerg Infect Dis. Aug 2020;26(8):1933–1935. PubMed PMID: 32339092. Pubmed Central PMCID: PMC7392467. Epub 2020/04/28. - PMC - PubMed
    1. Kuitunen I., Artama M., Makela L., Backman K., Heiskanen-Kosma T., Renko M. Effect of Social Distancing Due to the COVID-19 Pandemic on the Incidence of Viral Respiratory Tract Infections in Children in Finland During Early 2020. Pediatr Infect Dis J. Dec 2020;39(12):e423–e4e7. PubMed PMID: 32773660. Epub 2020/08/11. - PubMed
    1. Olsen S.J., Azziz-Baumgartner E., Budd A.P., Brammer L., Sullivan S., Pineda R.F., et al. Decreased Influenza Activity During the COVID-19 Pandemic - United States, Australia, Chile, and South Africa, 2020. MMWR Morb Mortal Wkly Rep. 2020 Sep 18;69(37):1305–1309. PubMed PMID: 32941415. Pubmed Central PMCID: PMC7498167 Journal Editors form for disclosure of potential conflicts of interest. Cheryl Cohen reports grants from Sanofi Pasteur and non-financial support from Parexel during the conduct of the study. No other potential conflicts of interest were disclosed. Epub 2020/09/18. - PMC - PubMed